289 related articles for article (PubMed ID: 25916999)
41. Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines.
Kumari S; Badana AK; Mohan GM; Shailender Naik G; Malla R
Biomed Pharmacother; 2017 Jul; 91():436-445. PubMed ID: 28475922
[TBL] [Abstract][Full Text] [Related]
42. S-Adenosylmethionine-mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells.
Cave DD; Desiderio V; Mosca L; Ilisso CP; Mele L; Caraglia M; Cacciapuoti G; Porcelli M
J Cell Physiol; 2018 Feb; 233(2):1370-1383. PubMed ID: 28518408
[TBL] [Abstract][Full Text] [Related]
43. Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells.
Bakhshaiesh TO; Armat M; Shanehbandi D; Sharifi S; Baradaran B; Hejazi MS; Samadi N
Asian Pac J Cancer Prev; 2015; 16(13):5191-7. PubMed ID: 26225652
[TBL] [Abstract][Full Text] [Related]
44. Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil.
Johnson KR; Fan W
Anticancer Res; 2002; 22(6A):3197-204. PubMed ID: 12530065
[TBL] [Abstract][Full Text] [Related]
45. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532.
Liu C; Zhou H; Sheng XB; Liu XH; Chen FH
Bioorg Chem; 2020 Sep; 102():104077. PubMed ID: 32682156
[TBL] [Abstract][Full Text] [Related]
47. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
48. Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.
Abedin MR; Powers K; Aiardo R; Barua D; Barua S
Sci Rep; 2021 Apr; 11(1):7347. PubMed ID: 33795712
[TBL] [Abstract][Full Text] [Related]
49. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway.
Hanna RK; Zhou C; Malloy KM; Sun L; Zhong Y; Gehrig PA; Bae-Jump VL
Gynecol Oncol; 2012 May; 125(2):458-69. PubMed ID: 22252099
[TBL] [Abstract][Full Text] [Related]
50. Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.
Qi Y; Fu X; Xiong Z; Zhang H; Hill SM; Rowan BG; Dong Y
PLoS One; 2012; 7(2):e31539. PubMed ID: 22348099
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
52. Curcuma zedoaria (Berg.) Rosc. essential oil and paclitaxel synergistically enhance the apoptosis of SKOV3 cells.
Zhou Y; Shen J; Xia L; Wang Y
Mol Med Rep; 2015 Jul; 12(1):1253-7. PubMed ID: 25777341
[TBL] [Abstract][Full Text] [Related]
53. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
Wang Z; Butt K; Wang L; Liu H
Nutr Cancer; 2007; 58(2):230-8. PubMed ID: 17640170
[TBL] [Abstract][Full Text] [Related]
54. The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel.
Goldblatt EM; Gentry ER; Fox MJ; Gryaznov SM; Shen C; Herbert BS
Mol Cancer Ther; 2009 Jul; 8(7):2027-35. PubMed ID: 19509275
[TBL] [Abstract][Full Text] [Related]
55. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D
Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543
[TBL] [Abstract][Full Text] [Related]
56. The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.
Liu H; Zang C; Schefe JH; Schwarzlose-Schwarck S; Regierer AC; Elstner E; Schulz CO; Scholz C; Possinger K; Eucker J
Anticancer Res; 2011 Sep; 31(9):2713-22. PubMed ID: 21868512
[TBL] [Abstract][Full Text] [Related]
57. Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells.
Kuo CH; Lu YC; Tseng YS; Shi CS; Chen SH; Chen PT; Wu FL; Chang YP; Lee YR
Breast Cancer; 2014 May; 21(3):358-69. PubMed ID: 22926505
[TBL] [Abstract][Full Text] [Related]
58. Morphine Can Inhibit the Growth of Breast Cancer MCF-7 Cells by Arresting the Cell Cycle and Inducing Apoptosis.
Chen Y; Qin Y; Li L; Chen J; Zhang X; Xie Y
Biol Pharm Bull; 2017 Oct; 40(10):1686-1692. PubMed ID: 28740043
[TBL] [Abstract][Full Text] [Related]
59. Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death.
Wang X; Wei S; Zhao Y; Shi C; Liu P; Zhang C; Lei Y; Zhang B; Bai B; Huang Y; Zhang H
Cancer Lett; 2017 Jan; 385():128-136. PubMed ID: 27810405
[TBL] [Abstract][Full Text] [Related]
60. Potent killing of paclitaxel- and doxorubicin-resistant breast cancer cells by calphostin C accompanied by cytoplasmic vacuolization.
Guo B; Hembruff SL; Villeneuve DJ; Kirwan AF; Parissenti AM
Breast Cancer Res Treat; 2003 Nov; 82(2):125-41. PubMed ID: 14692656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]